+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

H1, a novel derivative of tetrandrine reverse P-glycoprotein-mediated multidrug resistance by inhibiting transport function and expression of P-glycoprotein



H1, a novel derivative of tetrandrine reverse P-glycoprotein-mediated multidrug resistance by inhibiting transport function and expression of P-glycoprotein



Cancer ChemoTherapy and Pharmacology 67(5): 1017-1025



H1 is a novel derivative of tetrandrine (Tet). Here we investigate the ability of H1 to reverse P-glycoprotein (Pgp)-mediated multidrug resistance (MDR) and its mechanisms. KBv200, MCF-7/adr and their parental sensitive cell lines KB, MCF-7 were used for reversal study. The intracellular accumulation and efflux studies with Pgp substrates of doxorubicin and rhodamine 123 were determined by flow cytometry. The expression of Pgp was investigated by Western blot and RT-PCR analysis. ATPase activity of Pgp was performed by Pgp-Glo(™) assay systems. The ubiquitination level of Pgp was determined by immunoprecipitation analysis. The effect of ERK1/2 on Pgp expression in KBv200 cells were investigated by RNA interference. H1 significantly potentiated the sensitivity of Pgp substrates in KBv200 and MCF-7/adr cells, but not in parental cells KB and MCF-7. H1 inhibited Pgp expression in KBv200 cells in a dose-dependent manner, but had no effect on MDR1 expression. Further studies showed that H1 prompted the degradation of Pgp and decreased Pgp protein half-life by enhancing the ubiquitination of Pgp, which may be related to downregulated MEK-ERK signal pathway. We also found H1 inhibited ATPase activity of Pgp in a dose-dependent manner. H1 is an effectively and potential agent in reversing Pgp-mediated MDR by inhibiting the transport function and expression of Pgp.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 053458825

Download citation: RISBibTeXText

PMID: 20640574

DOI: 10.1007/s00280-010-1397-7


Related references

Tetrandrine and fangchinoline, bisbenzylisoquinoline alkaloids from Stephania tetrandra can reverse multidrug resistance by inhibiting P-glycoprotein activity in multidrug resistant human cancer cells. Phytomedicine 21(8-9): 1110-1119, 2015

Reversal of P-glycoprotein-mediated multidrug resistance by the novel tetrandrine derivative W6. Journal of Asian Natural Products Research 17(6): 638-648, 2015

Characterization of tetrandrine, a potent inhibitor of P-glycoprotein-mediated multidrug resistance. Cancer ChemoTherapy and Pharmacology 53(4): 349-356, 2004

Non-P-glycoprotein mediated mechanism for multidrug resistance precedes P-glycoprotein expression during in vitro selection for doxorubicin resistance in a human lung cancer cell line. Cancer Research 50(17): 5392-5398, 1990

Geniposide reverses multidrug resistance in vitro and in vivo by inhibiting the efflux function and expression of P-glycoprotein. Experimental and Therapeutic Medicine 13(2): 437-442, 2017

In vivo imaging of hepatobiliary transport function mediated by multidrug resistance associated protein and P-glycoprotein. Cancer ChemoTherapy and Pharmacology 54(2): 131-138, 2004

Persistent reversal of P-glycoprotein-mediated daunorubicin resistance by tetrandrine in multidrug-resistant human T lymphoblastoid leukemia MOLT-4 cells. Journal of Pharmacy and Pharmacology 55(11): 1531-1537, 2003

Reversal of P-glycoprotein-mediated multidrug resistance by XR9051, a novel diketopiperazine derivative. British Journal of Cancer 78(7): 885-892, 1998

The pipecolinate derivative VX-710 modulates multidrug resistance mediated by P-glycoprotein , multidrug resistance protein and breast cancer resistance protein. Proceedings of the American Association for Cancer Research Annual Meeting 44: 112, 2003

HZ08 reverse P-glycoprotein mediated multidrug resistance in vitro and in vivo. Plos one 10(2): E0116886, 2015

Reversal of P-glycoprotein-mediated multidrug resistance in vitro by AV200, a new ardeemin derivative. Cancer Letters 132(1-2): 45-50, 1998

Reversal of P-glycoprotein mediated multidrug resistance by a newly synthesized 1,4-benzothiazipine derivative, JTV-519. Cancer Letters 187(1-2): 111-119, 2002

Reversal of P-glycoprotein-mediated multidrug resistance in vitro by AV200, a new ardeemin derivative. Cancer Letters 132(1-2): 45-50, 1998

Metformin synergistically suppress tumor growth with doxorubicin and reverse drug resistance by inhibiting the expression and function of P-glycoprotein in MCF7/ADR cells and xenograft models. Oncotarget 9(2): 2158-2174, 2018

ZD6474 reverses multidrug resistance by directly inhibiting the function of P-glycoprotein. British Journal of Cancer 97(7): 934-940, 2007